4/22/2026
Amneal Pharmaceuticals Moves to Acquire Kashiv BioSciences in $1.1B+ Deal to Dominate the Biosimilar Wave
Amneal Pharmaceuticals (Nasdaq: AMRX) announced on April 21 that it has entered into a definitive agreement to acquire 100% of Kashiv BioSciences, LLC in a transaction that could exceed $1.1 billion in total value — a strategic bet on one of the most significant inflection points in the pharmaceutical industry in decades.
0
3 min read